NKA Bio
PrivateLast Round
Grant
Jan 1, 2025
Total Funding Raised
$1.44M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NKA Bio is a biotechnology company that develops biopharmaceuticals to improve critical care, specifically focusing on injectable antibody drugs for trauma resuscitation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Defense Tech, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NKA Bio Comparables
Compare NKA Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perfusion Medical | 84% | |
| Vivacelle Bio | 72% | |
| NuvOx Therapeutics | 62% |
NKA Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2025 | ||||
| Accelerator | Mar 11, 2024 | ||||
| Accelerator | Sep 5, 2023 |
Key People
Founding team and executive leadership
NKA Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| United States Air Force | Grant |
| U.S. Department of War | Grant |
| The Innovation Space | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 118% MoM.
NKA Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NKA Bio's valuation, stock price, and market status.
Is NKA Bio a public or private company?
NKA Bio is a private company.
What is the current stock price of NKA Bio?
NKA Bio is a private company with no public stock price. No recent secondary market data is available.
How much is NKA Bio worth (valuation)?
Valuation information for NKA Bio is not publicly available.
Can I buy NKA Bio stock?
NKA Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NKA Bio's last funding round?
NKA Bio's most recent funding round was Accelerator on March 11, 2024.
Who are the main investors in NKA Bio?
Key investors in NKA Bio include Techstars, The Innovation Space.
Will NKA Bio IPO soon?
No public IPO plans have been announced for NKA Bio.
How can I track NKA Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NKA Bio's secondary market activity and sign up for updates.